Literature DB >> 3298198

Effects of continuous positive airway pressure on upper airway and respiratory muscle activity.

C G Alex, R M Aronson, E Onal, M Lopata.   

Abstract

To study the effects of continuous positive airway pressure (CPAP) on lung volume, and upper airway and respiratory muscle activity, we quantitated the CPAP-induced changes in diaphragmatic and genioglossal electromyograms, esophageal and transdiaphragmatic pressures (Pes and Pdi), and functional residual capacity (FRC) in six normal awake subjects in the supine position. CPAP resulted in increased FRC, increased peak and rate of rise of diaphragmatic activity (EMGdi and EMGdi/TI), decreased peak genioglossal activity (EMGge), decreased inspiratory time and inspiratory duty cycle (P less than 0.001 for all comparisons). Inspiratory changes in Pes and Pdi, as well as Pes/EMGdi and Pdi/EMGdi also decreased (P less than 0.001 for all comparisons), but mean inspiratory airflow for a given Pes increased (P less than 0.001) on CPAP. The increase in mean inspiratory airflow for a given Pes despite the decrease in upper airway muscle activity suggests that CPAP mechanically splints the upper airway. The changes in EMGge and EMGdi after CPAP application most likely reflect the effects of CPAP and the associated changes in respiratory system mechanics on the afferent input from receptors distributed throughout the intact respiratory system.

Entities:  

Mesh:

Year:  1987        PMID: 3298198     DOI: 10.1152/jappl.1987.62.5.2026

Source DB:  PubMed          Journal:  J Appl Physiol (1985)        ISSN: 0161-7567


  15 in total

Review 1.  Continuous distending pressure.

Authors:  C Morley
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1999-09       Impact factor: 5.747

2.  Hypocapnia is associated with increased upper airway expiratory resistance during sleep.

Authors:  Abdul Ghani Sankri-Tarbichi; Nekeyua N Richardson; Susmita Chowdhuri; James A Rowley; M Safwan Badr
Journal:  Respir Physiol Neurobiol       Date:  2011-04-13       Impact factor: 1.931

Review 3.  Sleep.7: positive airway pressure therapy for obstructive sleep apnoea/hypopnoea syndrome.

Authors:  P Gordon; M H Sanders
Journal:  Thorax       Date:  2005-01       Impact factor: 9.139

4.  Waking genioglossal electromyogram in sleep apnea patients versus normal controls (a neuromuscular compensatory mechanism).

Authors:  W S Mezzanotte; D J Tangel; D P White
Journal:  J Clin Invest       Date:  1992-05       Impact factor: 14.808

5.  Influence of wakefulness on pharyngeal airway muscle activity.

Authors:  Yu-Lun Lo; Amy S Jordan; Atul Malhotra; Andrew Wellman; Raphael A Heinzer; Matthias Eikermann; Karen Schory; Louise Dover; David P White
Journal:  Thorax       Date:  2007-03-27       Impact factor: 9.139

6.  Effect of chronic continuous positive airway pressure (CPAP) therapy on upper airway size in patients with sleep apnoea/hypopnoea syndrome.

Authors:  I L Mortimore; P Kochhar; N J Douglas
Journal:  Thorax       Date:  1996-02       Impact factor: 9.139

Review 7.  Cardiorespiratory interaction with continuous positive airway pressure.

Authors:  Martino F Pengo; Sara Bonafini; Cristiano Fava; Joerg Steier
Journal:  J Thorac Dis       Date:  2018-01       Impact factor: 2.895

8.  The burden of obstructive sleep apnea in pediatric sickle cell disease: a Kids' inpatient database study.

Authors:  Po-Yang Tsou; Christopher M Cielo; Melissa S Xanthopoulos; Yu-Hsun Wang; Pei-Lun Kuo; Ignacio E Tapia
Journal:  Sleep       Date:  2021-02-12       Impact factor: 5.849

9.  Tonically discharging genioglossus motor units show no evidence of rate coding with hypercapnia.

Authors:  Patrick A Richardson; E Fiona Bailey
Journal:  J Neurophysiol       Date:  2010-01-06       Impact factor: 2.714

10.  Head helmet versus face mask for non-invasive continuous positive airway pressure: a physiological study.

Authors:  Nicolò Patroniti; Giuseppe Foti; Annamaria Manfio; Anna Coppo; Giacomo Bellani; Antonio Pesenti
Journal:  Intensive Care Med       Date:  2003-08-28       Impact factor: 17.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.